News

News

Hikma launches generic version of Vyvanse® following FDA approval

News

News

Hikma launches Vancomycin Hydrochloride for Injection, USP, in the US

News

News

Hikma and SK Biopharmaceuticals enter a strategic partnership for the Middle East and North Africa

Watch a video message from our new CEO, Riad Mishlawi

View our 2023 interim results presentation

Listen to our 2023 interim results Q&A call with our leadership team

#OwnYourCareer@Hikma

Meet Filipa Calisto, Associate Director, Portfolio & Commercial Operations, EU, and discover why she likes working at Hikma!

#OwnYourCareer@Hikma

Meet Kimberly Lembo, Associate Director, Contract Lifecycle Management and Systems, US and discover why she loves working at Hikma!

#OwnYourCareer@Hikma

Meet Alexander Liang, Trade Operations, US and discover why he loves working at Hikma!

Latest blogpost

Latest blogpost

Read the latest blog post by Lana Ghanem, Managing Director, Hikma Ventures and Vice President, Digital Health Investments & Partnerships - Investing in the disruptive future of the pharmaceutical industry.

Careers

Careers

Join us in helping to put better health within reach for millions of people

Find out more

Find out more

Our 2022 Sustainability Report

Find out more

Find out more

Our 2022 Annual Report